Drug intelligence / Profile preview

CHFX

Development stage: Preclinical
Lead developer: Institute of Chinese Medicine, The Chinese University of Hong Kong
Administration: Oral

Overview

CHFX is a simplified Chinese herbal formula developed in collaboration with the Institute of Chinese Medicine, CUHK. It is composed of four food-grade Chinese herbs: Wu-mei (Fructus Pruni Mume), Ling-zhi (Ganoderma), Huang-bai (Cortex Phellodendron), and Zhi-su (Perilla frutescens). This dietary supplement is currently being investigated in a pilot study for its potential to reduce allergic symptoms in food allergy, suggesting an immunomodulatory mechanism of action.

Other names: Chinese Herbal Formula - X

Beyond the preview

Go deeper on CHFX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CHFX.

Explore the full profile